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Methods: One hundred forty-seven caregiver/patient dyads were followed annually for 6 years in
three academic Alzheimer’s disease centers in the United States. Logistic, negative binomial, and
generalized linear mixed models were used to examine overall effects of caregiver/patient character-
istics on caregivers’ hospitalizations, doctor visits, outpatient tests and procedures, and prescription
and over-the-counter medications.
Results: Patients’ comorbid conditions and dependence were associated with increased health-care
use and costs of caregivers. Increases in caregiver depressive symptoms are associated with increases
in multiple domains of caregivers’ health-care use and costs.
Discussion: Findings suggest expanding our focus on dementia patients to include family caregivers
to obtain a fuller picture of effects of caregiving. Primary care providers should integrate caregivers’
needs in health-care planning and delivery. Clinical interventions that treat patients and caregivers as
a whole will likely achieve the greatest beneficial effects.
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In 2012, more than 5.4 million older adults in the United
States have dementia, two-thirds of whom live in the com-
munity and are cared for by family and friends [1]. A recent
report estimated the annual cost per person attributable to
dementia, including medical care, nursing home care, andthor. Tel.: 718-584-9000x6146; Fax: 718-741-4211.
rolyn.zhu@mssm.edu
nt matter  2014 The Alzheimer’s Association. All rights r
16/j.jalz.2013.12.018in-home formal and informal care, between $41,689 and
$56,290 [2]. If the proportion of individuals with dementia
living in the community remains stable, the burden of care-
giving on family and friends will increase exponentially.
The mental and physical health effects of caregiving on
family caregivers have been well documented. Compared
with noncaregivers, caregivers have higher rates of depres-
sion, stress, and other psychological problems [3–7]. They
also experience more physical problems, including lower
self-rated health, weakened immune system, and increased
cardiovascular problems [8–11]. Within the caregivereserved.
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dementia caregivers as they face unique challenges in
providing care because of the cognitive and physical
disability experienced by patients and long duration of
care [3–7].
Because of these negative health effects of caregiving,
economic and health consequences to dementia caregivers
can be substantial. A large and growing body of literature
has examined health and community services used by care-
givers of individuals with cognitively impairment [12–15].
However, the focus of the research has been on services
that are potentially helpful for the caregivers in their role
as caregivers. Results show that there is high need but
often low use of these services. Main barriers to use
include not knowing where to obtain services and that
many caregivers wait too long to use services, by which
time care recipients are often too frail to benefit. With few
exceptions, caregivers’ own health-care utilization has
received little attention [16]. An early study examined a
comprehensive set of health services use, including outpa-
tient, inpatient, and home health care, but did not separate
utilization by care recipient or caregiver [12,13]. Another
study reported slightly higher cost from hospitalizations
but lower cost from doctor visits in a sample of dementia
caregivers compared with noncaregivers with similar
socioeconomic characteristics, but the differences in
magnitude were small [17]. Similarly small but statistically
significant increases in caregivers’ medication cost as care-
giving hours increased have also been reported [18]. Care-
givers’ acute care utilization has been shown to increase as
patients’ behavioral and psychological symptoms and func-
tional status worsened [19]. More recent analyses from the
Resources for Enhancing Alzheimer’s Caregiver Health
study showed that caregivers’ hospitalization rates and prob-
ability of multiple doctors’ visit increased significantly dur-
ing an 18-month study period, but the use of primary care
and mental health service and select medication use (antide-
pressant and antianxiety medications) did not significantly
increase [20]. It is unclear, however, whether patients’ clin-
ical characteristics were included or how they might have
affected caregivers’ medical care use in that study.
The relationship between caregiving and caregivers’
health is typically described by the model of caregiver stress
by Pearlin et al. in a process in which both care recipient and
caregiver characteristics change over time but are important
determinants of caregiver outcomes [21]. In this model,
objective stressors are measured by the progression of care
recipients’ chronic illness and its decline. Typical outcomes
include type and quantity of caregiving, caregivers’ psycho-
logical stress, burden, and psychiatric and physical health.
Early models of the caregiving process emphasized
increased burden and stress over time, but longitudinal
studies suggested adaptations over time and stable caregiver
burden and depression [22,23]. In this study, we take
advantage of a rare opportunity of having both caregiver
and care recipient data in a longitudinal setting and extendthis model to examine caregivers’ medical care use and
related costs as outcomes. Because of the modest sample
size of our study, we estimated a set of reduced form
equations to examine the overall effects of patient and
caregiver characteristics on caregivers’ own medical care
use and related costs.2. Methods
2.1. Sample
Subjects for this study were recruited from the Predic-
tors 2 Study, a longitudinal study of individuals with prob-
able Alzheimer’s disease (AD) or dementia with Lewy
bodies prospectively followed from early stages of illness
in three sites: Columbia University College of Physicians
and Surgeons, Johns Hopkins University School of Medi-
cine, and Massachusetts General Hospital. Recruitment of
subjects in the Predictors 2 Study began in 1998 and ended
in 2012. Inclusion/exclusion criteria and evaluation
procedures of the Predictors 2 Study have been fully
described elsewhere [24,25]. Briefly, after an initial
evaluation, all subjects were diagnosed in a consensus
conference with at least two faculty neurologists or
psychiatrists specializing in dementia and one faculty
neuropsychologist. Subjects with AD met NINCDS-
ADRDA criteria for probable AD [26], and those with de-
mentia with Lewy bodies were diagnosed according to the
1996 consensus guidelines for the disease [27]. At study
entry, all subjects were required to have a modified Mini-
Mental State Examination (MMSE) score (21) 30, equiv-
alent to a score of 16 on the standard MMSE [28].
Subjects were also required to have at least one family
member/informant available. Subjects with parkinsonism,
stroke, alcoholism, schizophrenia, schizoaffective disor-
der, and electroconvulsive treatments were excluded. After
the baseline evaluation, all subjects were followed in per-
son semiannually until dropout or death, with annual as-
sessments of resource utilization. If subjects were unable
to travel to the clinic for evaluation, they were visited at
their residence (e.g., home, nursing home, or health-care
facility). There was 94% follow-up of subjects. The study
was approved by each local institutional review board.
The Predictors Caregiver Study was initiated 6 years af-
ter launching the Predictors 2 Study. A total of 180 care-
givers were active in the Predictors Study at the time of,
or subsequent to, the launching of the Predictors Caregiver
Study. Throughout the Caregiver study, these 180 care-
givers provided care for 160 subjects (care recipients here-
after). Of these 180 caregivers, health-care use data were
missing for 21 caregivers. Deleting these observations
leaves us with 159 caregivers with valid cost data for 147
care recipients. Of these 147 care recipients, 12 (8.2%)
had multiple caregivers who participated with the subject
at different times. We identified the caregiver who partici-
pated most often during the study as the subject’s main
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analysis. Thus, the longitudinal cohort used in this analysis
included 147 caregiver/care recipient dyads (for a total of
394 observations). On average, each dyad completed three
annual assessments.2.2. Measures2.2.1. Outcomes
At baseline and annually thereafter, caregivers reported
their own use of the following domains of medical care:
overnight hospitalizations, doctor visits, outpatient tests
and procedures (e.g., blood test, mammogram, urinalysis),
and assistive devices (e.g., walkers, grab bars). For those
who reported using a particular item, data on the intensity
of use (e.g., number of hospitalizations, number of doctor
visits) were also collected. Detailed information on pre-
scription and over-the-counter (OTC) medications the
caregiver took during the past 6 months including the
name of the drug, number of days taking the drug, and
number of pills per day were recorded on a concurrent
medication form. We annualized utilization rates when do-
mains were reported for less than a year (e.g., 3 months for
outpatient medical tests and procedures and 6 months for
medications). We converted physical quantities for each
domain of care into monetary values using costing
methods reported in earlier studies [29]. We then summed
across all domains to obtain a total annual medical care
cost for each caregiver. All cost values were adjusted to
constant 2010 US dollars using the medical care compo-
nent of the consumer price index [30]. Detailed descrip-
tions on data collection and price conversion were
reported earlier [31].
2.2.2. Caregiver characteristics
Caregiver age, gender, ethnicity, highest level of educa-
tion, and relationship to care recipient were recorded at the
start of the Caregiver Study. Whether the caregiver lived
with the care recipient, frequency of contact with the care
recipient, and length of time caregiver had known the
care recipient were recorded at each annual visit. Whether
caregiver assisted with basic activities of daily living
(BADL), including eating, dressing, bathing, and using
toilet, instrumental activities of daily living (IADL),
including shopping, household chores, personal business,
transportation, and social activities, average amount of
hours the caregiver spent per day on providing care,
whether a paid attendant assisted with care, and caregiver’s
employment status were reported annually. Caregiver co-
morbidities at baseline were computed using a modified
Charlson scale and included items for myocardial infarc-
tion, congestive heart failure, peripheral vascular disease,
hypertension, chronic obstructive pulmonary disease
(COPD), arthritis, gastrointestinal diseases, liver disease,
diabetes, chronic renal disease, and systemic malignancy[32]. Caregiver depressive symptoms were measured by
the six-item depression subsection of the Brief Symptom
Inventory (BSI) [33]. The instrument asked the caregivers
to rate on a five-point Likert scale how much during the
past week they were bothered by the following: feeling
lonely, feeling blue, feeling no interest in things, feeling
hopeless about the future, feelings of worthlessness, and
thoughts of ending his/her life. Response for each item
ranged from “not at all” to “extremely,” with higher scores
indicating higher depressive symptoms.
2.2.3. Care recipient characteristics
At the baseline visit, demographic characteristics (e.g.,
age, gender, ethnicity, highest level of education) were re-
corded. Because care recipients’ living arrangement may
change over time and patterns of health service utilization
and costs may differ substantially between individuals in
different living arrangements [34], information on care re-
cipients’ living arrangements (living at home, in retirement
homes, in assisted living facilities, or in nursing homes)
was collected at each visit.
Data on several clinical characteristics of the patient that
can be assessed reliably by a clinician were recorded at each
visit. Disease progression was characterized by transition
from milder stages of dementia to more severe stages,
measured by MMSE [28]. Care recipients’ dependence on
others was measured by the Dependence Scale (DS) [35],
a continuous index measuring the progressively greater
dependence on others. Columbia University Scale for Psy-
chopathology in Alzheimer’s Disease (CUSPAD), a semi-
structured interview administered by a physician or a
trained research technician, was used to measure the pres-
ence or absence of psychotic symptoms, behavior problems,
and depressive symptoms [36]. From the CUSPAD, we con-
structed a dichotomous variable to indicate the presence of
psychotic symptoms if the patient had any delusions, hallu-
cinations, or illusions [37,38]. We constructed a
dichotomous variable to indicate the presence of
behavioral problems if the patient had any of the following
five symptoms: wandering away from home or caregiver,
verbal outbursts, physical threats or violence, agitation or
restlessness, or sundowning (more confusion at night or
during evening compared with the day). We also
constructed a dichotomous variable to indicate the
presence of depressive symptoms if the patient had any
depressed mood (i.e., sad, depressed, blue, down in the
dumps) and either had difficulty sleeping or had a change
in appetite. Comorbidities included items for myocardial
infarction, congestive heart failure, peripheral vascular
disease, hypertension, COPD, arthritis, gastrointestinal
diseases, liver disease, diabetes, chronic renal disease, and
systemic malignancy from the baseline visit.
2.2.4. Analysis
We estimated a set of reduced form equations to provide
estimates of the overall effects of patient and caregiver
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examined three sets of outcomes: any medical care use, in-
tensity of use, and costs.
For any medical care use, estimations were performed us-
ing random-effects logistic regressions. Dependent variables
included any hospitalizations, any doctor visits, any pre-
scription medication, any outpatient treatment/procedures,
and any OTC medication. Because more than 93% of the
caregivers reported using some medical care, we did not es-
timate an overall model for any medical care use. Estimates
for any use models are exponentiated and represent adjusted
odds ratios (ORs).
For intensity of use, dependent variables included num-
ber of doctor visits, number of prescription medications,
number of outpatient treatment/procedures, and number of
OTC medications. We did not estimate a model for number
of hospitalizations because only 46 hospitalizations were re-
ported throughout the study. Intensity of use was examined
using negative binomial regressions. We chose negative
binomial over Poisson regressions because with count
data, it is more robust when the variance is not equivalent
to the mean of the distribution and it models between-
subject heterogeneity [39]. It is unclear whether different
processes govern zero and nonzero counts. We compared
our results from our models, which assume the same pro-
cesses for zero and nonzero counts, with those obtained
from zero-inflated negative binomial models, which assume
different processes for zero and nonzero counts. Results
were substantively similar, and we therefore chose the
simpler and more familiar negative binomial models. Esti-
mates for intensity of use models are exponentiated and
represent incidence rate ratios (IRRs).
For caregivers who used a particular domain of medical
care, we then estimated a generalized linear mixed regres-
sion model for its related cost. Similar to models on intensity
of use, we did not estimate models for hospitalizations
because of its low use rates. In addition to the four models
of medical care use, a model estimating total cost of medical
care was also estimated. Because the distributions of the cost
variables were highly positively skewed, we constructed log-
transformed costs as dependent variables. Estimates for the
cost models are interpreted as semielasticities, that is, per-
centage change in cost from a unit change in the independent
variable.
For all three sets of models, we first examined bivariate
association between caregivers’ medical care use and each
caregiver/care recipient characteristic. Variables that were
not significantly associated with caregivers’ medical care
use in bivariate analyses were dropped from our final
models. We tested several interaction terms between care
recipient characteristics (dependence and chronic condi-
tions) and caregiver characteristics (chronic conditions
and depressive symptoms). They were statistically insignif-
icant and were dropped from the analyses. Our final model
therefore included the following independent variables for
the caregiver: baseline age, gender, education, comorbidconditions, depressive symptoms (measured by the depres-
sion subsection of the BSI), and an indicator for a spouse
caregiver. Care recipient characteristics included in the
final models were baseline comorbid conditions, DS, indi-
cator for whether the care recipient was depressed, and in-
dicator for the presence of psychiatric problems. All
caregiver and care recipient clinical characteristics, except
baseline comorbid conditions, were time-varying current
values.
Because of the longitudinal nature of the study, caregivers
could contribute multiple observations in the study. We
included a random intercept term to allow between-person
variations and a random slope term to allow within-person
variations over time [40]. Fixed effects of time were esti-
mated by including indicators for assessment intervals
[41]. All models controlled for indicators for site as fixed ef-
fects. All analyses were performed using Stata 9.0 [42].3. Results
3.1. Caregiver and care recipient characteristics at
baseline
The typical caregiver in this sample was 65 years old
(standard deviation [SD], 13.4), female (76%), white
(84%), and a college graduate with 16 years of schooling
(SD, 3.3; Table 1). Slightly more than half of the caregivers
were spouses (55%) and a third were adult children (35%).
The caregivers were relatively healthy, reporting fewer than
one chronic condition at baseline. The most prevalent
chronic conditions reported were hypertension (24%),
depression (10%), diabetes (6%), and cancer (6%). Other
chronic conditions were reported by less than 5% of the
caregivers. The most commonly reported medications
included antihypertensive agents (26%), medications for
dyslipidemia (18%), and psychotropic medications
(12%). Other medications were reported by less than 10%
of the caregivers. Slightly more than a third of the care-
givers reported being employed at the time (37%). Those
who were working reported an average of 32 work hours/
wk (SD, 18). Three-fourths of the caregivers helped with
IADLs (78%) and about half with BADLs (47%). Among
those who provided help, caregivers reported spending an
average of 3 h/d helping with IADLs (SD, 2.6) and 2 hours
on activities of daily living (ADLs) (SD, 1.9). A small frac-
tion of caregivers also reported having other helpers who
provided IADL (18%) or ADL help (14%). Among those
with other helpers, caregivers reported that other helpers
spent an average of 3 h/d helping with either ADLs or
IADLs.
The typical care recipient in this sample was 76 years old
(SD, 7.3), female (55%), white (90%), had an average of
15 years of schooling (SD, 3.2), and had fewer than one
chronic condition at baseline (mean, 0.8; SD, 1.1) other
than dementia. The most prevalent chronic conditions for
the care recipients included hypertension (34%), depression
Table 1
Baseline demographic characteristics of caregiver/care recipient dyads
(n 5 147)
Variables Mean 6 SD
Caregiver characteristics
Age (y) 65.2 6 13.4
Younger than 65 (%) 47.6
65–74 (%) 24.5





Years of schooling 15.9 6 3.3













Other psychotropic medications 12.2
Vitamins 8.1
Depressive symptoms* 8.1 6 3.1
Employment status (%)
Currently working 37.4
Hours of work per weeky 31.9 6 18.2
Provided help with IADL/BADLs (%)
IADL 78.2
ADL 46.9
Other helpers helped with IADL 17.7
Other helpers helped with ADL 13.6
Hours of help per dayy
IADL 3.1 6 2.6
ADL 2.4 6 1.9
Other helpers helped with IADL 0.6 6 1.6
Other helpers helped with ADL 0.5 6 1.7
Total hours from all helpersy 5.4 6 6.2
Care recipient characteristics
















MMSE (range, 0–30) 17.4 6 7.7
Mild AD: MMSE 21 (%) 42.9
Moderate AD, MMSE 10–20 (%) 38.4
Severe AD, MMSE ,10 (%) 18.8
(Continued )
Table 1
Baseline demographic characteristics of caregiver/care recipient dyads
(n 5 147) (Continued )
Variables Mean 6 SD
Dependence Scale (range, 0–15) 6.7 6 3.1
Presence of psychotic symptoms (%) 44.2
Abbreviations: SD, standard deviation; IADL, instrumental activities of
daily living; BADL, basic activities of daily living; ADL, activities of daily
living; COPD, chronic obstructive pulmonary disease;MMSE,Mini-Mental
State Examination; AD, Alzheimer’s disease.
*Depressive symptoms are measured by the six-item depression subsec-
tion of the Brief Symptom Inventory (range, 0–30).
yHours of work and hours of help are computed among those who were
employed and provided help only.
zPrevalence of other comorbid conditions were all ,5%.
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of other chronic conditions were low: myocardial infarction,
congestive heart failure, and cancer were present in 4% of
the sample, and chronic liver disease and renal disease
were present in 2% of the sample. At baseline, most of the
care recipients were living at home (69%), and the rest
was evenly split between living in retirement homes (16%)
or in nursing homes (15%). Average MMSE score at base-
line was 17.4 (SD, 7.7) and DS score was 6.7 (SD, 3.1).3.2. Caregiver baseline and overall medical care use and
cost
At baseline, 93% of the caregivers reported using some
type of medical care; 10 (6.8%) reported not using any med-
ical care (Table 2). During the entire study period, 4 of the
147 caregivers reported not using any medical care at all.
Across all assessments (n 5 401), no medical care use was
reported only 6.6% of the time (n 5 26).
At baseline, 10% of caregivers reported being hospital-
ized at least once during the previous assessment interval,
three-fourths (74%) had a doctor visit, and 65% received
outpatient tests and procedures. A quarter of caregivers
(26%) used assistive devices. Prescription (76%) and OTC
(58%) medications were common. Average annual medical
care cost was estimated at $2585 (SD, 6386) in the year
before baseline assessment, with the most expensive compo-
nents being hospitalizations (mean, $1122; 43.4% of total
cost) and prescription medications ($798; 30.9%).
Table 2 also presents data on overall use and cost
throughout the study period. Time trend in caregiver medical
care use and costs was statistically insignificant for all do-
mains except for prescription and OTC medication use,
where they both decreased slightly (both P , .05).3.3. Multivariate results on utilization
Not surprisingly, caregivers’ own chronic conditions
were associated with increased likelihood of having any doc-
tor visits (OR, 2.493; P, .01) and hospitalization (OR, 1.67;
P , .10), although the association with hospitalization was
Table 2








Any use 93.2 93.4
Hospitalizations 10.2 11.7
Prescription medications 75.5 70.1
Doctor visits 74.1 75.4
Over-the-counter (OTC) medications 57.8 48.2
Outpatient tests/procedures 64.6 67.0
Assistive devices 25.9 24.1
Intensity of use among users, mean 6 SD
Number of hospital admissions 1.1 6 0.5 1.2 6 0.6
Number of nights at hospital 3.9 6 5.1 4.8 6 4.7
Number of doctor visits 2.8 6 4.6 2.7 6 4.4
Number of assistive devices 1.4 6 1.0 1.5 6 1.0
Number of outpatient tests/procedures 2.8 6 2.3 2.7 6 2.2
Number of prescription medications 3.2 6 2.4 3.3 6 2.6
Number of OTC medications 3.3 6 2.5 3.2 6 2.4
Cost per person, mean $ 6 SD
Total 2585 6 6386 3068 6 6993
Hospitalizations 1122 6 5754 1503 6 6088
Prescription medications 798 6 994 868 6 1253
Outpatient tests/procedures 412 6 851 448 6 903
Doctor visits 154 6 301 160 6 298
Assistive devices 53 6 178 54 6 204
OTC medications 46 6 110 34 6 85
Abbreviation: SD, standard deviation.
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givers’ BSI depression subsection score was associated with
increased likelihood of prescription (OR, 1.112; P , .05)
and OTC (OR, 1.117; P , .05) medication use. After con-
trolling for caregiver health, demographic characteristics
were largely not associated with medical care use, except
that older caregivers were more likely to use outpatient tests
(OR, 1.192; P , .01).
Several care recipient characteristics were associated
with caregiver medical care use. In particular, care recipi-Table 3









Age in 5-y increments 1.099 (0.140) 1.145 (0.101) 1
Female 1.131 (0.651) 1.831 (0.815) 1
Year of schooling 0.967 (0.068) 1.069 (0.068) 1
Baseline comorbid conditions 1.670 (0.454)* 2.493 (0.870)*** 1
Brief Symptom Inventory (BSI) 1.025 (0.056) 1.079 (0.064) 1
Care recipient
Baseline comorbid conditions 1.185 (0.244) 1.557 (0.328)** 1
Dependence Scale (DS) 0.962 (0.074) 1.160 (0.071)** 1
Depressed 0.533 (0.407) 1.495 (0.839) 0
Presence of psychiatric problems 2.083 (0.914)* 0.892 (0.299) 1
Spouse caregiver 2.247 (1.507) 1.758 (0.844) 1
Abbreviations: OR, odds ratio; SE, standard error.
NOTE. *P , .10; **P , .05; ***P , .01.ents’ chronic conditions were associated with caregivers’
increased likelihood of doctor visits (OR, 1.557; P , .05)
and use of outpatient tests and procedures (OR, 1.319;
P , .05). Care recipients’ DS score was also associated
with caregivers’ increased likelihood of doctor visits (OR,
1.116; P , .05) and use of outpatient tests and procedures
(OR, 1.106; P , .05). Care recipients’ psychiatric problems
were associated with caregivers’ increased likelihood of
prescription medication use (OR, 1.801; P , .05) and hos-
pitalization (OR, 2.083; P , .10), although the association
with hospitalization was marginally significant. Compared
with adult children and other caregivers, spouse caregivers
were more likely to use prescription (OR, 1.841; P , .10)
and OTC (OR, 2.043; P , .10) medications, although the
effects were only marginally significant.3.4. Multivariate results on intensity of use
Among caregivers who reported using medical care,
caregivers’ own chronic conditions were associated with
increases in the number of doctor visits (IRR, 1.271;
P , .01), number of prescription medications (IRR,
1.432; P , .01), and, to a lesser extent, number of outpa-
tient tests and procedures (IRR, 1.073; P , .10)
(Table 4). Caregivers’ BSI depression subsection score
was significantly associated with all four domains of med-
ical care: number of doctor visits (IRR, 1.036; P , .01),
number of outpatient tests and procedures (IRR, 1.044;
P , .01), number of OTC medications (IRR, 1.038;
P , .05), and, to a lesser extent, prescription medications
(IRR, 1.023; P , .10). As expected, caregivers who were
older had more doctor visits (IRR, 1.068; P , .10), outpa-
tient tests and procedures (IRR, 1.100; P , .05), and pre-
scription (IRR, 1.061; P , .10) and OTC (IRR, 1.102;
P , .05) medications. In addition, female caregivers and
caregivers with more schooling also had more doctor visits
and OTC medications, although their effects were only







.192 (0.074)*** 1.145 (0.079) 1.127 (0.087)
.486 (0.440) 1.850 (0.609)* 1.640 (0.622)
.000 (0.041) 0.929 (0.046) 1.061 (0.054)
.102 (0.203) 1.171 (0.259) 1.380 (0.296)
.052 (0.042) 1.112 (0.053)** 1.117 (0.050)**
.319 (0.171)** 1.014 (0.125) 0.961 (0.135)
.106 (0.046)** 1.040 (0.048) 0.958 (0.048)
.860 (0.304) 0.636 (0.248) 0.525 (0.245)
.244 (0.308) 1.801 (0.493)** 0.788 (0.227)
.428 (0.464) 1.841 (0.681)* 2.043 (0.842)*
Table 4









(OTC) medications, IRR (SE)
Caregiver
Age in 5-y increments 1.068 (0.038)* 1.100 (0.033)** 1.061 (0.036)* 1.102 (0.050)**
Female 1.378 (0.239)* 1.154 (0.174) 0.948 (0.159) 1.538 (0.345)*
Year of schooling 1.048 (0.024)** 0.992 (0.018) 0.971 (0.020) 1.054 (0.029)*
Baseline comorbid conditions 1.271 (0.110)*** 1.073 (0.079)* 1.432 (0.121)*** 1.121 (0.128)
Brief Symptom Inventory (BSI) 1.036 (0.016)** 1.044 (0.015)*** 1.023 (0.014)* 1.038 (0.020)**
Care recipient
Baseline comorbid conditions 1.076 (0.065) 1.094 (0.055)* 1.034 (0.063) 0.970 (0.080)
Dependence Scale (DS) 1.026 (0.023) 1.046 (0.021)** 1.017 (0.020) 0.995 (0.028)
Depressed 0.999 (0.205) 0.938 (0.174) 0.864 (0.178) 0.699 (0.199)
Presence of psychiatric problems 1.010 (0.123) 1.154 (0.130) 1.169 (0.118) 0.899 (0.142)
Spouse caregiver 1.072 (0.203) 1.150 (0.184) 1.398 (0.244)** 1.862 (0.436)***
Abbreviations: IRR, incidence rate ratio; SE, standard error.
NOTE. *P , .10; **P , .05; ***P , .01.
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ated with the intensity of caregivers’ medical care use,
except for care recipients’ chronic conditions (IRR, 1.094;
P , .10) and DS score (IRR, 1.046; P , .05), which
increased the number of outpatient tests and procedures
the caregivers had.
3.5. Multivariate results on costs
By far the most influential variable that affects care-
givers’ total medical care is caregivers’ own chronic condi-
tions (Table 5). Each additional chronic condition was
associated with a 33.2% increase in total medical care
cost. Caregivers’ chronic conditions were also associated
with a 13.4% increase in the cost of doctor visits and
33.3% increase in the cost of prescription medications
(both P , .05). Increases in caregivers’ depressive symp-
toms, as measured by the BSI depression subsection score,
were also associated with increases in caregivers’ medical
care cost. Each point increase in caregivers’ BSI score wasTable 5









Age in 5-y increments 0.078 (0.057) 0.041 (0.025)* 0
Female 20.141 (0.284) 0.252 (0.122)** 0
Year of schooling 20.032 (0.038) 0.022 (0.016) 0
Baseline comorbid conditions 0.332 (0.158)** 0.134 (0.062)** 20
Brief Symptom Inventory (BSI) 0.042 (0.024)* 0.036 (0.013)*** 0
Spouse caregiver 0.444 (0.299) 0.007 (0.135) 20
Care recipient
Baseline comorbid conditions 0.057 (0.106) 0.000 (0.041) 0
Dependence Scale (DS) 20.003 (0.033) 20.007 (0.017) 0
Depressed 0.121 (0.345) 20.205 (0.139) 0
Presence of psychiatric problems 0.267 (0.171) 0.064 (0.092) 0
Number of observations 368 296 264
Abbreviations: Coeff., coefficient; SE, standard error.
NOTE. *P , .10; **P , .05; ***P , .01.associated with a 3.6% increase in the cost of doctor visits,
a 10% increase in the cost of outpatient treatment/proce-
dures (both P , .01), and a 4% increase in total medical
care cost (P , .10).
Care recipients’ characteristics were largely not associ-
ated with caregivers’ medical care cost, except for care re-
cipients’ chronic conditions and DS score, which were
marginally associated with higher cost of outpatient tests
and procedures (P , .10).
4. Discussion
Providing care to individuals with dementia often has
negative health consequences for caregivers. In this study,
we extend Pearlin model to examine caregivers’ own
health-care use in a longitudinal setting. We followed a sam-
ple of dementia caregivers who participated along with their
care recipients in a natural history study of dementia and
estimated in a set of reduced form models overall effects







.074 (0.056) 0.044 (0.057) 0.082 (0.068)
.407 (0.270) 20.251 (0.283) 0.521 (0.339)
.003 (0.034) 20.008 (0.038) 0.061 (0.043)
.038 (0.141) 0.333 (0.159)** 20.067 (0.173)
.101 (0.028)*** 0.021 (0.019) 0.017 (0.029)
.096 (0.283) 20.106 (0.296) 0.444 (0.380)
.150 (0.093)* 20.033 (0.110) 20.104 (0.127)
.063 (0.036)** 20.013 (0.029) 0.016 (0.042)
.342 (0.321) 0.403 (0.366) 20.422 (0.449)
.277 (0.208) 20.065 (0.141) 20.030 (0.215)
276 190
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caregivers’ medical care use and costs. Not surprisingly, the
most consistent predictors of caregivers’ medical care use
and costs were caregivers’ own physical and mental health.
Higher comorbid conditions were associated with care-
givers’ increased likelihood of hospitalizations and doctor
visits and also with increases in the number of doctor visits
and prescription medications and their related costs. Each
additional comorbid condition was associated with a 33% in-
crease in the caregivers’ total medical care cost. Consistent
with existing literature [43], we found that caregivers’
depressive symptoms were independently associated with
caregivers’ likelihood of using prescription and OTC medi-
cations, number of doctor visits, and outpatient tests and pro-
cedures as well as related costs.
The relationship between caregivers’ depressive symp-
toms and health-care cost is of note. Improvements on care-
giver depression have been consistently reported in dementia
caregiver intervention programs [44,45]. However, little is
known of the effects of reduced depressive symptoms on
caregiver health-care costs. This lack of information has
impeded widespread adoption of successful interventions.
Although the Predictors Study is a natural history study of
dementia, our results suggest that improvements in caregiver
depressive symptoms are associated with modest reductions
in multiple domains of caregivers’ medical care use and
costs and fill an important gap toward understanding inter-
vention’s full benefit.
In addition to caregivers’ own characteristics, our results
showed an independent effect of caregiving on caregivers’
health-care use. After controlling for caregivers’ own socio-
demographic and health characteristics, objective stressors
of care recipients’ disease severity and clinical characteris-
tics remain important predictors of caregivers’ medical
care utilization. In particular, care recipients’ comorbidities
and dependence on others were associated with increases in
caregivers’ likelihood of doctor visits and outpatient tests
and procedures. Presence of psychiatric symptoms in the
care recipient was associated with an almost two-fold in-
crease in caregivers’ likelihood of using prescription medi-
cations. These results are consistent with an earlier study
that showed dementia patients’ behavioral and psychologi-
cal problems and functional status were associated with
caregivers’ emergency care and hospitalizations [19]. Inter-
estingly, both studies also reported that cognitive impair-
ment itself was not associated with caregiver’s medical
care use. These results are consistent with the literature
that behavioral symptoms in dementia patients are important
predictors of caregiving time, caregiver burden, quality of
life, and other negative outcomes [22,46–48]. In other
studies, however, behavioral problems have been shown to
be unrelated to caregiver service use, and the effects of
care recipient behavioral problems were small compared
with the effects of ADL problems [14]. Together, these re-
sults highlight the difficulties of managing behavioral symp-
toms of dementia and suggest that behavioral symptomshave differential effects on different dimensions of caregiver
health and health-care use.
Our study did not, however, find strong associations be-
tween care recipient characteristics and caregivers’ intensity
of medical care use and costs. Care recipients’ dependence
on others had a small significant effect on the number and
costs of outpatient tests and procedures caregivers had.
Care recipients’ comorbidities were also only marginally
associated with the number and costs of outpatient tests
and procedures caregivers had. It is unclear why care recip-
ient characteristics were not more strongly associated with
caregivers’ intensity of medical use [49]. As a secondary
analysis, we examined high-intensity use using several
different cutoff points (e.g., 3, 5 prescription medica-
tions) and found substantively similar results. These results
are consistent with an earlier report comparing costs of hos-
pitalization and doctor visits using data from a sample of
caregivers of veterans with dementia with those from non-
caregivers with similar socioeconomic characteristics [17].
In the present sample of caregivers whose provision of care-
giving hours was relatively low, perhaps, the burden of care-
giving has not led the caregivers to neglect their ownmedical
care needs. Perhaps, this sample of well-educated caregivers
has more resources available to them, limiting our ability to
detect differences in their health-care use and expenditures.
It is worth noting that these data are based on caregiver self-
report of utilization and are subject to recall bias. Such non-
differential misclassification is likely to result in reducing
estimated effect. It may also be possible that the overall
burden of caregiving is more likely to impact overall utiliza-
tion patterns than the intensity of use. It is also possible that
instead of caregiver and patient characteristics indepen-
dently affecting caregiver health-care utilization as modeled
in this study, caregiver health (e.g., chronic conditions) is a
consequence of patients’ dementia. More research in this
area is clearly needed.
There are several limitations to our study. First, patients
were selected from tertiary care university hospitals and
specialized AD centers and are a nonrandom sample of in-
dividuals affected by the disease in the general population.
Patients in our sample were predominantly white, highly
educated, and healthier than community-based samples.
Caution is needed in generalizing the results of this study
to patients of other ethnicities, patients at lower education
and income levels, and to community AD patients. Second,
it should be noted that for analysis of health-care use and
costs, our sample may be somewhat underpowered. With
this in mind, we attempted to include a parsimonious set
of independent variables in our estimation models. Third,
because the Predictors Study is a natural history study of
dementia, no interventions were conducted, and compari-
son data on individuals without dementia or their care-
givers were not available. Therefore, we chose to
estimate a set of reduced form equations, providing esti-
mates of total effects of exogenous patient and caregiver
variables on caregiver health-care use. Several hypotheses
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increasing caregiving demands, measured by care recipi-
ents’ clinical characteristics, could negatively affect care-
giver health through wear and tear, thereby increase
caregivers’ health-care use. On the other hand, if caregivers
adapt to their caregiving role, care recipients’ clinical char-
acteristics may not strongly affect caregivers’ health or
health-care use. It is also possible that caregivers may
ignore their own health and health-care use because of
high cost of care and the tremendous amount of time
devoted to care provision. Testing these structural mecha-
nisms of caregiving is beyond the scope of the present
study. It is worth noting that in this cohort of caregivers,
health-care utilization remained stable over time, suggest-
ing adaptation in caregiving, or more complex mechanisms
that affect caregiving health-care use are present. Important
next steps include examining the structural mechanisms of
caregiving, examination of caregiver health-care use out-
comes through intervention studies, and including compar-
ison groups to estimate the effects of caregiving on
caregiver health-care use due to dementia.
The ultimate goal of health services research is to
improve health outcomes of care recipients and caregivers.
With the aging of the population and increases in the size of
population with dementia, the effects of caregiving on care-
giver health and health-care use will continue to be impor-
tant at both the individual and societal level. Beyond the
direct measures and costs of dementia patients’ health-
care utilization, results from this study suggest that there
is a direct effect of dementia on caregivers’ health-care
use. It is imperative that we expand our focus on dementia
patients to include family caregivers. In terms of commu-
nity services provided to the caregivers, access to and
involvement of a social worker has been shown to be
important in linking caregivers to available support. Pri-
mary care providers, although central to coordinating
health-care delivery to the care recipients, could be an
important link in integrating caregivers’ needs while plan-
ning and delivering health-care services to patients. Clin-
ical interventions that treat the patients and their
caregivers as a whole will most likely achieve the greatest
beneficial effects.Acknowledgments
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1 Systematic review: Providing care to individuals with
dementia can often have negative health consequences.
As a result, economic and health consequences to de-
mentia caregivers can be substantial. However, most
studies have focused on the patient. With few excep-
tions, caregiver health-care utilization has received
little attention. The goal of this study was to examine
the effects of caregiver and patient characteristics on
caregivers’ medical care use and cost.
2 Interpretation: In this present study, we take advan-
tage of a rare opportunity of having both caregiver
and care recipient data in a longitudinal setting and
examine whether, and how, caregivers’ medical care
use and related costs are associated with their own
health and sociodemographic characteristics as well
as care recipients’ increasing dementia severity and
clinical characteristics. We hypothesize that care-
givers’ medical care use and costs will increase as
care recipients’ health declines, and the effects on
caregivers’ health-care use will vary by objective
stressors and by domain of care. Our results show that
patients’ comorbid conditions and dependence were
associated with increased health-care use and costs of
caregivers. Improvements in caregiver depressive
symptoms are associated with modest reductions in
multiple domains of caregivers’ medical care use and
costs.
3 Future directions: Findings suggest that we should
expand our focus on dementia patients to include
family caregivers to obtain a fuller picture of effects
of caregiving. For example, although improvements
on caregiver depression have been consistently re-
ported in dementia caregiver intervention programs,
little is known of the effects of reduced depressive
symptoms on caregiver health-care costs. This lack
of information has impeded widespread adoption of
successful interventions. However, because the Pre-
dictors Study is a natural history study of dementia,
no interventions were conducted, and comparison
data on individuals without dementia or their care-
givers were not available. Therefore, we chose to
estimate a set of reduced form equations, providing
estimates of total effects of exogenous patient and
caregiver variables on caregiver health-care use.
Important next steps include examination of caregiver
health-care use outcomes through intervention
studies and including comparison groups to estimate
the effects of caregiving on caregiver health-care use
due to dementia.
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